Laminin γ2 is identified as a metastatic marker with high expression in a number of cancers 45, including LUAD 23 and pancreatic ductal adenocarcinoma 46 because it enhances metastatic potential through integrin β1, ZEB1, and SNAI1-mediated EMT 23. Here, SNAI1 is linked to pancreatic ductal adenocarcinoma.